NFKB1 and pulmonary emphysema: Because of the activation of NF-κB, an increased level of Bax and downregulation of Nrf2 and Bcl-2 have been reported in the lung tissue of emphysema patients [15,16], thus, OMT has the great potential to alleviate emphysema via modulating these signaling pathways.